Latest Intelligence on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Pfizer strikes in the battle for the US Alzheimer's market

Published By Datamonitor
28 Sep 2000
CommentWire
CommentWire

DuPont / Kos Pharmaceuticals: a good combination for dyslipidemia

Published By Datamonitor
28 Sep 2000
Expert View
Expert View

Making the most of new indications

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

Vitamin C: benefits of supplements still in question

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

UCB: winning European market with novel anti-epileptic?

Published By Datamonitor
05 Oct 2000
CommentWire
CommentWire

AVAX: cell banking heralds new era in cancer care

Published By Datamonitor
09 Oct 2000
CommentWire
CommentWire

Anti-platelets: NICE ruling for Merck and Co

Published By Datamonitor
11 Oct 2000
CommentWire
CommentWire

Cephalon/Anesta: painful times could be ahead

Published By Datamonitor
12 Oct 2000
Expert View
Expert View

Inoculating the cancer market

Published By Datamonitor
13 Oct 2000
CommentWire
CommentWire

Pfizer: more pressure on inhaled insulins

Published By Datamonitor
16 Oct 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.